SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1001)12/10/1997 12:23:00 AM
From: Mike Heimbuch  Respond to of 2173
 
Tommysdad

Thanks for the DIAB reply - I posted a long answer on their SI board

Mike H



To: Andrew H who wrote (1001)12/10/1997 4:48:00 PM
From: D.Right  Read Replies (1) | Respond to of 2173
 
Dear Andrew:

Time and patience indeed. Actrally, with the updated trial plan, we will see the completions of patient enrollment for European trials in the first quarter of 1998 and for U.S. trials in the second quarter of 1998 (please, no more delays, AMLN). I am sure attention will come back to AMLN in a positive way just as you stated in your post. I don't think it will take very long for that to happen.

Good day

D.Right


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News